225 related articles for article (PubMed ID: 15035279)
21. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
[TBL] [Abstract][Full Text] [Related]
22. Gamma knife radiosurgery for nonfunctioning pituitary adenomas.
Muacevic A; Uhl E; Wowra B
Acta Neurochir Suppl; 2004; 91():51-4. PubMed ID: 15707025
[TBL] [Abstract][Full Text] [Related]
23. Recurrence rates after neuroendoscopic fenestration and Gamma Knife surgery in comparison with subtotal resection and Gamma Knife surgery for the treatment of cystic craniopharyngiomas.
Park YS; Chang JH; Park YG; Kim DS
J Neurosurg; 2011 May; 114(5):1360-8. PubMed ID: 19877807
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic Radiosurgery as the Initial Treatment for Patients with Nonfunctioning Pituitary Adenomas.
Hasegawa T; Shintai K; Kato T; Iizuka H
World Neurosurg; 2015 Jun; 83(6):1173-9. PubMed ID: 25700971
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
[TBL] [Abstract][Full Text] [Related]
26. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results.
Kobayashi T; Kida Y; Mori Y
J Neurosurg; 2002 Dec; 97(5 Suppl):422-8. PubMed ID: 12507068
[TBL] [Abstract][Full Text] [Related]
27. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
[TBL] [Abstract][Full Text] [Related]
28. Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
Pomeraniec IJ; Kano H; Xu Z; Nguyen B; Siddiqui ZA; Silva D; Sharma M; Radwan H; Cohen JA; Dallapiazza RF; Iorio-Morin C; Wolf A; Jane JA; Grills IS; Mathieu D; Kondziolka D; Lee CC; Wu CC; Cifarelli CP; Chytka T; Barnett GH; Lunsford LD; Sheehan JP
J Neurosurg; 2018 Sep; 129(3):648-657. PubMed ID: 29076785
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas.
Sicignano G; Losa M; del Vecchio A; Cattaneo GM; Picozzi P; Bolognesi A; Mortini P; Calandrino R
Radiother Oncol; 2012 Jul; 104(1):119-24. PubMed ID: 22647658
[TBL] [Abstract][Full Text] [Related]
30. Gamma knife radiosurgery for pituitary adenoma: early results.
Petrovich Z; Yu C; Giannotta SL; Zee CS; Apuzzo ML
Neurosurgery; 2003 Jul; 53(1):51-9; discussion 59-61. PubMed ID: 12823873
[TBL] [Abstract][Full Text] [Related]
31. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.
Losa M; Mortini P; Barzaghi R; Ribotto P; Terreni MR; Marzoli SB; Pieralli S; Giovanelli M
J Neurosurg; 2008 Mar; 108(3):525-32. PubMed ID: 18312100
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of multisession gamma knife radiosurgery for residual or recurrent pituitary adenomas.
Albano L; Losa M; Nadin F; Barzaghi LR; Parisi V; Del Vecchio A; Bolognesi A; Mortini P
Endocrine; 2019 Jun; 64(3):639-647. PubMed ID: 30798432
[TBL] [Abstract][Full Text] [Related]
33. Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery.
Choi JY; Chang JH; Chang JW; Ha Y; Park YG; Chung SS
Yonsei Med J; 2003 Aug; 44(4):602-7. PubMed ID: 12950114
[TBL] [Abstract][Full Text] [Related]
34. Boost Gamma Knife surgery during multimodality management of adult medulloblastoma.
Germanwala AV; Mai JC; Tomycz ND; Niranjan A; Flickinger JC; Kondziolka D; Lunsford LD
J Neurosurg; 2008 Feb; 108(2):204-9. PubMed ID: 18240913
[TBL] [Abstract][Full Text] [Related]
35. Tumor shrinkage assessed by volumetric MRI in long-term follow-up after fractionated stereotactic radiotherapy of nonfunctioning pituitary adenoma.
Kopp C; Theodorou M; Poullos N; Jacob V; Astner ST; Molls M; Grosu AL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1262-7. PubMed ID: 21530099
[TBL] [Abstract][Full Text] [Related]
36. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience.
Pollock BE; Cochran J; Natt N; Brown PD; Erickson D; Link MJ; Garces YI; Foote RL; Stafford SL; Schomberg PJ
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1325-9. PubMed ID: 18029107
[TBL] [Abstract][Full Text] [Related]
37. Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes.
Sheehan JP; Pouratian N; Steiner L; Laws ER; Vance ML
J Neurosurg; 2011 Feb; 114(2):303-9. PubMed ID: 20540596
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiosurgery of pituitary adenomas.
Liščák R; Ježková J; Marek J
Neurosurg Clin N Am; 2013 Oct; 24(4):509-19. PubMed ID: 24093569
[TBL] [Abstract][Full Text] [Related]
39. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
[TBL] [Abstract][Full Text] [Related]
40. Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas.
Losa M; Spatola G; Albano L; Gandolfi A; Del Vecchio A; Bolognesi A; Mortini P
Endocrine; 2017 Jun; 56(3):595-602. PubMed ID: 27688011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
